Finance Home - My Yahoo - Yahoo! - Help

Wednesday, December 30, 2009, 9:28PM ET - U.S. Markets Closed. Dow  0.03% Nasdaq  0.13%

Poniard Pharmaceuticals, Inc. (PARD)

At 4:00PM ET: 1.88   0.08 (4.44%)

MORE ON PARD

Quotes Summary Real-Time Options Historical Prices Charts Interactive Basic Chart Basic Tech. Analysis News & Info Headlines Financial Blogs Company Events Message Board Company Profile Key Statistics SEC Filings Competitors Industry Components Analyst Coverage Analyst Opinion Analyst Estimates Research Reports Star Analysts Ownership Major Holders Insider Transactions Insider Roster Financials Income Statement Balance Sheet Cash Flow

Headlines Get Headlines for:
Change Display [ hide $$  edit ] Thu, Dec 24, 2009 • PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Thu, Dec 24) Tue, Dec 22, 2009 • Poniard Pharmaceuticals Announces $6.5 Million Financing PR Newswire (Tue, Dec 22) Mon, Dec 21, 2009 • PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Mon, Dec 21) Mon, Dec 7, 2009 • Options Trader: Monday Market Movement at Seeking Alpha (Mon, Dec 7) Tue, Dec 1, 2009 • PONIARD PHARMACEUTICALS, INC. Files SEC form 8-K, Other Events, Financial Statements and Exhibits EDGAR Online (Tue, Dec 1) Mon, Nov 23, 2009 • ARCA, FortuNet: Midday Volume Plays at TheStreet.com (Mon, Nov 23) • Poniard Finds Cash to Keep Lights On: BioBuzz at TheStreet.com (Mon, Nov 23) • Poniard Announces $7.4 Million Financing PR Newswire (Mon, Nov 23) Fri, Nov 20, 2009 • Biotech Stocks: Inovio soars, Novavax falls in early action at MarketWatch (Fri, Nov 20) Wed, Nov 18, 2009 • Poniard Pharmaceuticals' Gamble Doesn't Pay Off at Seeking Alpha (Wed, Nov 18) • Poniard, Netlist: Early Volume Plays at TheStreet.com (Wed, Nov 18) • Poniard Pharma downgraded by Canaccord Adams Briefing.com (Wed, Nov 18) Tue, Nov 17, 2009 • Poniard rebounds on picoplatin colon cancer data AP (Tue, Nov 17) • Poniard Pharmaceuticals Announces Updated Positive Clinical Data from Phase 2 Trial of Picoplatin in Colorectal Cancer and New Phase 1 Cardiac Safety Trial Results PR Newswire (Tue, Nov 17) • Trading Overview for Poniard Pharmaceuticals Inc. Issued by Beacon Equity GlobeNewswire (Tue, Nov 17) • BioMed News Bytes: Cytori, Poniard, Alkermes, Spherix, CRXX, HGSI at Seeking Alpha (Tue, Nov 17) Mon, Nov 16, 2009 • American Diary, Poniard Pharmaceuticals: Biggest Price Decliners (ADY, PARD) at The Wall Street Journal Online (Mon, Nov 16) • Monday Options Recap at Seeking Alpha (Mon, Nov 16) • Poniard plunges on failure of picoplatin study AP (Mon, Nov 16) • Poniard's CEO Pulls a Belichick: BioBuzz at TheStreet.com (Mon, Nov 16) Older Headlines - Download Recent Headlines View headlines from: Mon, Nov 16, 2009Mon, Nov 9, 2009Mon, Nov 2, 2009Mon, Oct 26, 2009Mon, Oct 19, 2009Mon, Oct 12, 2009Mon, Oct 5, 2009Mon, Sep 28, 2009Mon, Sep 21, 2009Mon, Sep 14, 2009 Add PARD News to My Yahoo!:
Add to Portfolio     Set Alert     Email to a Friend Get Headlines for Another Symbol: Symbol Lookup • Stocks In Play • Story Stocks • Full Coverage